China’s very own Sinovac COVID-19 vaccine has been approved by the World Health Organisation (WHO) for emergency use. The vaccine allegedly prevented symptomatic disease in 51% in vaccinated individuals, as well as severe symptoms along with hospitalisation in 100% of samples. This is the second Chinese vaccine to get the WHO green light as it follows in Sinopharm’s footsteps.
The vaccine has been approved for over 18s in several countries, with the second dose being administered two to four weeks later. Getting an emergency approval means a vaccine has met international standards for safety, efficacy and manufacturing. A whopping 95% decrease in deaths in a Brazilian city was noted following citizens receiving a Sinovac jab. The introduction of this new vaccine will hopefully see the Covax programme, which aims to ensure vaccine fair access, get a boost as it struggles with supply problems.
#MaltaDaily
Photo Source: DW